XML 143 R119.htm IDEA: XBRL DOCUMENT v3.6.0.2
Net Sales by Commercial Franchise (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenue from External Customer [Line Items]                      
Net sales $ 2,645 $ 2,558 $ 2,585 $ 2,375 $ 2,603 $ 2,487 $ 2,475 $ 2,403 $ 10,163 $ 9,968 $ 10,719
Renal                      
Revenue from External Customer [Line Items]                      
Net sales [1]                 3,855 3,789 4,172
Hospital Products                      
Revenue from External Customer [Line Items]                      
Net sales                 6,308 6,179 6,547
Hospital Products | Fluid Systems                      
Revenue from External Customer [Line Items]                      
Net sales [2]                 2,300 2,106 2,129
Hospital Products | Integrated Pharmacy Solutions                      
Revenue from External Customer [Line Items]                      
Net sales [3]                 2,245 2,297 2,535
Hospital Products | Surgical Care                      
Revenue from External Customer [Line Items]                      
Net sales [4]                 1,321 1,323 1,373
Hospital Products | Other                      
Revenue from External Customer [Line Items]                      
Net sales [5]                 $ 442 $ 453 $ 510
[1] The Renal segment is presented as a separate commercial franchise and includes sales of the company’s PD, HD and CRRT.
[2] Principally includes IV therapies, infusion pumps, and administration sets.
[3] Includes sales of the company’s premixed and oncology drug platforms, nutrition products and pharmacy compounding services.
[4] Includes sales of the company’s inhaled anesthesia products as well as biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.
[5] Principally includes sales from the company’s pharmaceutical partnering business.